Vol 1 (September 2018): Precision Cancer Medicine

Meet the Professor
Philippe Lambin: how advances in imaging impact precision radiation oncology?
Julia Wang
Precision Cancer Medicine  
2018;
1:
17  
Mini-Review
What is the best drug as a front-line treatment for EGFR activating mutation?
Hidetaka Uramoto
Precision Cancer Medicine  
2018;
1:
16  
Editorial
PLX51107, a promising novel bromodomain and extra-terminal inhibitor in chronic lymphoid leukemia treatment
Claes Wahlestedt, Ines Lohse
Precision Cancer Medicine  
2018;
1:
14  
Editorial
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis
Precision Cancer Medicine  
2018;
1:
13  
Editorial
Fatty acids: from adipocytes to cancer cells
Hiu Yee Kwan
Precision Cancer Medicine  
2018;
1:
12